FtsZ as an Antibacterial Target: Status and Guidelines for Progressing This Avenue
Authors:
- Kennardy D. KusumaKKKennardy D. Kusuma
- Matthew PayneMPMatthew Payne
- Alison Thavary UngAUAlison Thavary Ung
- Amy L. BottomleyABAmy L. Bottomley
- Elizabeth J. HarryEHElizabeth J. Harry
- 3 July 2019
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (8) , 1279-1294
Abstract
The disturbing increase in the number of bacterial pathogens that are resistant to multiple, or sometimes all, current antibiotics highlights the desperate need to pursue the discovery and development of novel classes of antibacterials. The wealth of knowledge available about the bacterial cell division machinery has aided target-driven approaches to identify new inhibitor compounds. The main division target being pursued is the highly conserved and essential protein, FtsZ. Despite very active research on FtsZ inhibitors for several years, this protein is not yet targeted by any commercial antibiotic. Here we discuss the suitability of FtsZ as an antibacterial target for drug development, and review progress achieved in this area. We use hindsight to highlight the gaps that have slowed progress in FtsZ inhibitor development, and to suggest guidelines for concluding that FtsZ is actually the target of these molecules, a key missing link in several studies. In moving forward, a multidisciplinary and a communicative and collaborative process, with sharing of research expertise, is critical if we are to succeed.Keywords
Funding Information
- Australian Research Council (DP150102062)
This publication has 119 references indexed in Scilit:
- Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam AntibioticsScience Translational Medicine, 2012
- Challenges of Antibacterial DiscoveryClinical Microbiology Reviews, 2011
- Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular AgentsJournal of Medicinal Chemistry, 2010
- Membrane potential is important for bacterial cell divisionProceedings of the National Academy of Sciences, 2010
- Chrysophaentins A−H, Antibacterial Bisdiarylbutene Macrocycles That Inhibit the Bacterial Cell Division Protein FtsZJournal of the American Chemical Society, 2010
- Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical PropertiesJournal of Medicinal Chemistry, 2010
- The Antibacterial Cell Division Inhibitor PC190723 Is an FtsZ Polymer-stabilizing Agent That Induces Filament Assembly and CondensationJournal of Biological Chemistry, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Filamentation byEscherichia colisubverts innate defenses during urinary tract infectionProceedings of the National Academy of Sciences, 2006
- Protein–protein interactions as targets for small molecule drug discoveryPeptide Science, 2006